Clinical Trial Update: A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ferrous bisglycinate chelate to ferrous ascorbate for efficacy and tolerability in iron deficiency anemia has completed, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferrous ascorbate (ferrous ascorbate)
• Ferrous bisglycinate chelate (ferrous bisglycinate chelate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haematopoiesis | Phase 3 | Status: COMPLETED | Results posted: 2018-04-13